AGP Picks
View all

The most trusted news from Massachusetts

Provided by AGP

Massachusetts Weekly
Got News to Share?
Got News to Share? globe Explore more publications!

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 21, 2026

MadHat Media Formalizes Equity Engineering Partnership with SapientSwift Solutions to Accelerate Global DDARP Deployment
May 21, 2026

MadHat Media Formalizes Equity Engineering Partnership with SapientSwift Solutions to Accelerate Global DDARP Deployment

Indeterminate EIN Presswire
MadHat Media Engages Ricci Capital Partners to Lead Series A Capital Formation
May 21, 2026

MadHat Media Engages Ricci Capital Partners to Lead Series A Capital Formation

Indeterminate EIN Presswire
Ricci Capital Partners Leadership Joins MadHat Media Board of Advisors
May 21, 2026

Ricci Capital Partners Leadership Joins MadHat Media Board of Advisors

Indeterminate EIN Presswire
Choate Expands Intellectual Property Litigation Practice with Former Finnegan Attorney Marta Garcia
May 21, 2026

Choate Expands Intellectual Property Litigation Practice with Former Finnegan Attorney Marta Garcia

Indeterminate EIN Presswire
LiveData Launches LiveData Insights AI Advisor to Give Every Hospital Leader Real Time Answers from the Operating Room
May 21, 2026

LiveData Launches LiveData Insights AI Advisor to Give Every Hospital Leader Real Time Answers from the Operating Room

Indeterminate EIN Presswire
First Time In Boston: Multi-Million Dollar Display Of Five Famous, Misprinted U.S. Postage Stamps Side-by-Side
May 21, 2026

First Time In Boston: Multi-Million Dollar Display Of Five Famous, Misprinted U.S. Postage Stamps Side-by-Side

Indeterminate EIN Presswire
Influential Women Highlights Lindsay Pope: Driving Procurement Excellence Through Leadership and Innovation
May 21, 2026

Influential Women Highlights Lindsay Pope: Driving Procurement Excellence Through Leadership and Innovation

Indeterminate EIN Presswire
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

Indeterminate GlobeNewswire
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 21, 2026

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Indeterminate GlobeNewswire
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 21, 2026

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Indeterminate GlobeNewswire
Lili Latin Dance Celebrates Three Years of Community, Culture and Connection in Boston
May 21, 2026

Lili Latin Dance Celebrates Three Years of Community, Culture and Connection in Boston

Indeterminate EIN Presswire
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
May 21, 2026

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Indeterminate GlobeNewswire
Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models
May 21, 2026

Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models

Indeterminate GlobeNewswire
Scientists map which genes are active in a developing seed to build hardier crops
May 21, 2026

Scientists map which genes are active in a developing seed to build hardier crops

Indeterminate EIN Presswire
Bierman Autism Centers Tests New ABA Curriculum Built to Help Children Make Faster Progress
May 21, 2026

Bierman Autism Centers Tests New ABA Curriculum Built to Help Children Make Faster Progress

Indeterminate EIN Presswire
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
May 21, 2026

Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
May 21, 2026

Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC

Indeterminate GlobeNewswire
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
May 21, 2026

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy

Indeterminate GlobeNewswire
Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting
May 21, 2026

Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting

Indeterminate GlobeNewswire
AMSC to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 27, 2026
May 21, 2026

AMSC to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 27, 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.